Detalhe da pesquisa
1.
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Lancet Oncol
; 16(7): 816-29, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092818
2.
The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.
Open Forum Infect Dis
; 11(6): ofae233, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38854392
3.
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
J Natl Cancer Inst
; 105(9): 654-63, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23425564